Longeveron Inc. has entered into a Purchase Agreement for a private placement, raising $15 million through the sale of Class A common stock and Series A Preferred Stock. The financing aims to support ongoing clinical development and extend cash runway into Q4 2026.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.